According to KYORIN Pharmaceutical's latest financial reports the company's total debt is ยฃ0.14 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-03-31 | ยฃ0.10 B | -15.28% |
2023-03-31 | ยฃ0.12 B | -4.34% |
2022-03-31 | ยฃ0.13 B | -5.74% |
2021-03-31 | ยฃ0.14 B | -18.96% |
2020-03-31 | ยฃ0.17 B | 6.42% |
2019-03-31 | ยฃ0.16 B | 361.1% |
2018-03-31 | ยฃ36.04 M | -9% |
2017-03-31 | ยฃ39.6 M | -0.66% |
2016-03-31 | ยฃ39.87 M | 79.25% |
2015-03-31 | ยฃ22.24 M | 68.78% |
2014-03-31 | ยฃ13.17 M | -7.4% |
2013-03-31 | ยฃ14.23 M | -46.99% |
2012-03-31 | ยฃ26.84 M | -52.14% |
2011-03-31 | ยฃ56.09 M | 130.29% |
2010-03-31 | ยฃ24.35 M | -34.94% |
2009-03-31 | ยฃ37.44 M | 189.35% |
2008-03-31 | ยฃ12.94 M | 100.73% |
2007-03-31 | ยฃ6.44 M | -30.95% |
2006-03-31 | ยฃ9.33 M | |
2005-03-31 | N/A |